Charles Schwab Investment Management Inc Mustang Bio, Inc. Transaction History

Charles Schwab Investment Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.58 - $1.13 $95,477 - $186,017	-164,617 Reduced 84.03%	31,286 $19,000
Q4 2021 Feb 11, 2022	BUY	$1.66 - $2.64 $28,303 - $45,012	17,050 Added 9.53%	195,903 $326,000
Q2 2021 Aug 16, 2021	BUY	$2.7 - $3.81 $165,196 - $233,111	61,184 Added 52.0%	178,853 $594,000
Q4 2020 Feb 16, 2021	BUY	$2.66 - $4.18 $126,246 - $198,386	47,461 Added 67.6%	117,669 $446,000
Q3 2020 Nov 13, 2020	SELL	$3.01 - $3.88 $18,309 - $23,602	-6,083 Reduced 7.97%	70,208 $222,000

Q2 2020 Aug 14, 2020	BUY	$2.33 - $4.6 $13,693 - $27,034	5,877 Added 8.35%	76,291 $243,000
Q2 2019 Aug 09, 2019	BUY	$2.66 - $6.28 $70,849 - $167,267	26,635 Added 60.84%	70,414 $260,000
Q1 2019 May 14, 2019	BUY	$2.95 - $5.61 $36,813 - $70,007	12,479 Added 39.87%	43,779 $150,000
Q2 2018 Aug 08, 2018	BUY	$6.68 - $11.0 $209,084 - $344,300	31,300 New	31,300 $216,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $46.3M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.